ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22)
Clinical trials for ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22) explained in plain language.
Never miss a new study
Get alerted when new ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22) trials appear
Sign up with your email to follow new studies for ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for Tough-to-Treat blood cancers
Disease control CompletedThis study tested a combination of two drugs, azacitidine and sirolimus, in 57 adults with high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that came back or didn't respond to standard treatment. The goal was to see if the combination could improve blood c…
Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22)
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. First, patients received low-dose chemotherapy and radiation to prepare their bodies. Then, they got donor stem cells followed by drugs to prevent the donor cells from atta…
Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22)
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC